Brief: Nicox Announces Publication Of Pre-Clinical Efficacy Results On New Class Of IOP-Lowering Compounds

Nicox SA

23/02/2021 06:39

Feb 23 (Reuters) - NICOX SA  NCOX.PA :
    * ANNOUNCES THE PUBLICATION IN LEADING SCIENTIFIC JOURNAL OF
PRE-CLINICAL EFFICACY RESULTS ON A NEW CLASS OF NON-PGA
NO-DONATING IOP-LOWERING COMPOUNDS
    * NEW CLASS WORKS SOLELY THROUGH NITRIC OXIDE (NO)-MEDIATED
ACTIVITY
    * EQUIVALENT INTRAOCULAR PRESSURE (IOP) LOWERING AND FASTER
ONSET
OF ACTIVITY DEMONSTRATED VERSUS. PROSTAGLANDIN ANALOG (PGA)
TRAVOPROST

Source text for Eikon:  ID:nGNE2MKnXT 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))